{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07313761","recordId":"NCT07313761","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07313761-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct07313761.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct07313761.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-12-19","publishedAt":"2026-08-23","recordId":"NCT07313761","recordSha256":"871da0cf6b4daec213a0b649454086edcd617259bde1d9a1b1278c8febde6c83","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07313761?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2026-01-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-05","publishedAt":"2026-08-23","recordId":"NCT07313761","recordSha256":"67e72a68166ad82551036c3beec2b87f8b3c0381ddb337c0b209febfeeb151c9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07313761?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2026-03-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-18","publishedAt":"2026-08-23","recordId":"NCT07313761","recordSha256":"0a769d0d04590ae1d7d01b624e2b4ac6d930c1cce306afd9975c74a9552d1873","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07313761?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2026-07-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-07-15","publishedAt":"2026-08-23","recordId":"NCT07313761","recordSha256":"f6306be29148f350e707cde934ef360e3b66f9bf0fcdfa42c0b5074751c443f6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07313761?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2026-08-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-08-06","publishedAt":"2026-08-23","recordId":"NCT07313761","recordSha256":"857ae4fc8ae0f5ac060a55e160c24e0ab865c55ccda904acf8ca6f65fdbe7124","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07313761?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"a497dae274a4fe7a5d570d0de9573ed6e3f7ee4a41bee51c0540f9304a542b39"}}